Terry Chrisomalis | TalkMarkets | Page 1

Terry Chrisomalis

Pharma/Biotech Analyst
I am a graduate of Industrial and Business Service Management. I have been investing and writing about biotechnology stocks for many years now and have extensive experience writing about the science and companies themselves. I am a contributor to more
Following: 59 Followers: 3433

Articles

Latest Posts
1 to 16 of 353 Posts
1 2 3 ... 23 >>>
Protalix BioTherapeutics Pipeline Progress
Wednesday, July 29, 2020 9:54 AM EDT
Protalix Biotherapeutics (PLX) offers great potential in the coming months as its lead candidate, PLX-102 - a therapy for Fabry disease, is edging closer to the finish line.
In this article: PLX, SNY Also: ITMR, BLRX, BCLI, BLPH, PSTI
Read
Exclusive Interview With Lindsay Rosenwald, CEO Of Fortress Biotech 
Thursday, February 27, 2020 5:57 AM EDT
I recently had the opportunity to interview Lindsay A. Rosenwald, CEO of Fortress Biotech, Inc. (FBIO), an innovative biopharmaceutical company.
In this article: FBIO Also: JNJ, HLUYY
Read
Matinas Biopharma Is Highly Undervalued
Monday, September 9, 2019 7:13 AM EDT
With cash concerns put to rest, a solid lead product MAT9001, and a unique lipid nano-crystal delivery technology, I believe Matinas Biopharma is highly undervalued.
In this article: MTNB Also: LGND, XOMA, AMRN, ABUS
Read
Bellicum Is Worth A Look With Multiple Catalysts On The Way In 2nd Half Of 2019
Thursday, September 5, 2019 8:46 AM EDT
Bellicum is a highly undervalued biotech. Especially, when you consider that it has two types of technology that can be utilized to potentially alter how CAR-T therapies are produced.
In this article: BLCM
Read
Finally A Real Cancer Diagnosis Breakthrough?
Friday, May 3, 2019 8:04 AM EDT
TOMDF is a diagnostics company that utilizes blood tests for early detection of cancer and neurodegenerative diseases. But is it a good investment? I took a deeper look and reached out to the company's CEO, Herman Weiss, to get the facts.
In this article: TOMDF, AMBS
Read
Rexahn's Deal With China For RX-3117 Candidate Moves It Back On The Right Track
Tuesday, April 16, 2019 4:43 PM EDT
Rexahn Pharma generates a deal in Greater China for its clinical cancer product. Here's what you need to know...
In this article: RNN, MRK
Read
CVR Medical: A New Approach To Cardiovascular Care
Monday, November 13, 2017 10:17 AM EDT
CVR Medical's proprietary device could change the spectrum of stroke prevention and diagnostics.
In this article: CRRVF
Read
VistaGen Therapeutics: Interesting Prospects
Tuesday, October 3, 2017 10:54 AM EDT
VistaGen's drug AV-101 has breakthrough potential for treatment of depression and other indications.
In this article: VTGN Also: AGN
Read
OncoSec Raising Its Profile In Fight Against Cancer
Wednesday, September 6, 2017 9:01 AM EDT
New trials expect to build on previous results to quickly gain FDA approval.
In this article: ONCS, MRK Also: BMY
Read
20 Questions For NuLife Sciences CEO John B. Hollister
Tuesday, August 15, 2017 12:26 PM EDT
An inside look at a small company looking to have a big impact in transplant technology.
In this article: NULF
Read
Teva Pharmaceuticals Posts Positive Phase 3 Results In Migraine Study
Thursday, June 1, 2017 1:33 PM EDT
The drug that was tested in the phase 3 trial in patients with migraine is known as fremanezumab. With the positive phase 3 results, the company is looking to submit the Biologics License Application — BLA — to the FDA .
In this article: TEVA
Read
Inovio Pharmaceuticals Surges Higher On Positive HIV Vaccine Results
Saturday, May 27, 2017 12:00 PM EDT
Recently Inovio Pharmaceuticals (INO) announced positive results for an early stage HIV vaccine study. The vaccine produced one of the best immune responses seen to date in a human HIV clinical trial.
In this article: GILD Also: INO
Read
EnteroMedics Acquires Medical Device Producer BarioSurg
Saturday, May 27, 2017 10:18 AM EDT
Around 1.38 mil will be in in EnteroMedics common shares, and up to 1 million in convertible preferred shares. Through the acquisition, the Vest System and its vBloc product can be combined to create improved weight loss options.
In this article: ETRM
Read
Puma Biotechnology Soars After Positive Briefing Documents By FDA For Neratinib
Monday, May 22, 2017 7:21 PM EDT
Puma Biotechnology stock soars 50% on release of positive briefing docs but analysts still warn that approval is no sure thing.
In this article: PBYI
Read
GlycoMimetics Surges 100% On Breakthrough Therapy Designation
Sunday, May 21, 2017 11:52 PM EDT
On Thursday, GlycoMimetics surged as high 100% after the company announced that it had received FDA breakthrough therapy designation.
In this article: GLYC
Read
AstraZeneca Achieves Positive Phase 3 Results In Late Stage Cancer Trial
Sunday, May 14, 2017 3:52 AM EDT
On Friday, AstraZeneca announced that it had achieved positive results in a phase 3 lung cancer study. The key drug used in the trial, Imfinzi, was shown to greatly cut the risk of death in lung cancer patients.
In this article: AZN Also: MRK
Read
1 to 16 of 353 Posts
1 2 3 ... 23 >>>